$KOAN
Resonate Blends Inc Stock $koan

$koan Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000149315223018479 Filed on May 22, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q4
Revenue	$6.361K	$10.11K	$8.580K
YoY Change	124.29%	-63.45%	-55.91%
Cost Of Revenue	$4.685K	$8.572K	$8.070K
YoY Change	93.52%	-33.34%	17.98%
Gross Profit	$1.676K	$1.535K	$510.00
YoY Change	303.86%	-89.62%	-95.96%
Gross Profit Margin	26.35%	15.19%	5.94%
Selling, General & Admin	$50.23K	$98.42K	$239.9K
YoY Change	-82.59%	-84.92%	-45.6%
% of Gross Profit	2997.02%	6411.73%	47039.22%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.940K	$3.000K	$1.230K
YoY Change	13.45%
% of Gross Profit	115.75%	195.44%	241.18%
Operating Expenses	$50.23K	$98.42K	$241.1K
YoY Change	-82.69%	-84.99%	-45.9%
Operating Profit	-$48.56K	-$96.89K	-$240.6K
YoY Change	-83.25%	-84.88%	-44.44%
Interest Expense	-$317.5K	-$186.4K	-$57.21K
YoY Change	-161.07%	-116.28%	-105.41%
% of Operating Profit
Other Income/Expense, Net	-$353.8K	-$284.1K	$10.13K
YoY Change	-170.54%
Pretax Income	-$402.3K	-$381.0K	-$110.3K
YoY Change	-290.01%	-177.74%	-117.67%
Income Tax
% Of Pretax Income
Net Earnings	-$402.3K	-$381.0K	-$110.3K
YoY Change	-290.01%	-177.74%	-117.67%
Net Earnings / Revenue	-6324.63%	-3769.19%	-1284.97%
Basic Earnings Per Share	-$0.01	-$0.01
Diluted Earnings Per Share	-$0.01	-$0.01	$0.00
COMMON SHARES
Basic Shares Outstanding	76.66M shares	75.44M shares	75.41M shares
Diluted Shares Outstanding		75.44M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.260K	$1.040K	$64.42K
YoY Change	-93.51%	-99.44%	398.99%
Cash & Equivalents	$2.260K	$1.042K	$64.42K
Short-Term Investments
Other Short-Term Assets	$435.0K		$0.00
YoY Change	2889.69%		-100.0%
Inventory	$101.0K	$115.1K	$160.5K
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$658.3K	$236.1K	$374.9K
YoY Change	108.62%	-50.56%	39.1%
LONG-TERM ASSETS
Property, Plant & Equipment	$19.17K	$21.11K	$24.11K
YoY Change	-28.0%	-25.5%	-23.06%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$100.00	$100.00	$100.00
YoY Change	0.0%	0.0%	0.0%
Other Assets			$0.00
YoY Change
Total Long-Term Assets	$19.27K	$21.21K	$24.21K
YoY Change	-27.89%	-25.41%	-22.99%
TOTAL ASSETS
Total Short-Term Assets	$658.3K	$236.1K	$374.9K
Total Long-Term Assets	$19.27K	$21.21K	$24.21K
Total Assets	$677.6K	$257.3K	$399.1K
YoY Change	97.96%	-49.15%	32.62%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$298.4K	$236.9K	$319.6K
YoY Change	20.74%	-5.32%	54.5%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$1.984M	$1.508M	$988.8K
YoY Change	-20.76%	-36.25%	-46.98%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.777M	$2.026M	$1.546M
YoY Change	-18.44%	-46.46%	-64.89%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.777M	$2.026M	$1.546M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$2.777M	$2.026M	$1.546M
YoY Change	-18.44%	-46.46%	-64.89%
SHAREHOLDERS EQUITY
Retained Earnings	-$26.10M	-$25.70M	-$25.32M
YoY Change	3.29%		-2.52%
Common Stock	$7.833K	$7.544K	$7.544K
YoY Change	63.73%		67.5%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$2.099M	-$1.769M	-$1.147M
YoY Change
Total Liabilities & Shareholders Equity	$677.6K	$257.3K	$399.1K
YoY Change	97.96%	-49.15%	32.62%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q4
OPERATING ACTIVITIES
Net Income	-$402.3K	-$381.0K	-$110.3K
YoY Change	-290.01%	-177.74%	-117.67%
Depreciation, Depletion And Amortization	$1.940K	$3.000K	$1.230K
YoY Change	13.45%
Cash From Operating Activities	-$28.78K	$145.3K	$48.38K
YoY Change	-94.58%	-130.37%	-109.09%
INVESTING ACTIVITIES
Capital Expenditures			$0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$435.0K	$0.00
YoY Change
Cash From Investing Activities	-$435.0K	$0.00	$0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	465.0K	-$208.6K	-258.8K
YoY Change	21.9%	-132.1%	-267.35%
NET CHANGE
Cash From Operating Activities	-28.78K	$145.3K	48.38K
Cash From Investing Activities	-435.0K	0.000	0.000
Cash From Financing Activities	465.0K	-$208.6K	-258.8K
Net Change In Cash	1.220K	-$63.38K	-210.4K
YoY Change	-100.81%		-44.27%
FREE CASH FLOW
Cash From Operating Activities	-$28.78K	$145.3K	$48.38K
Capital Expenditures			$0.00
Free Cash Flow			$48.38K
YoY Change			-109.09%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023Q1	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1		usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		usd
CY2023Q1	KOAN	Gain On Settlement Of Notes Payable GainOnSettlementOfNotesPayable		usd
CY2023Q1	KOAN	Share Professional Fees Compensation ShareProfessionalFeesCompensation		usd
CY2023Q1	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties		usd
CY2022Q1	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables		usd
CY2023Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
CY2023Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
CY2022Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
CY2022Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
CY2022Q1	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt		usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000897078
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	KOAN	Common Stock Issuable CommonStockIssuable		usd
CY2023Q1	KOAN	Non Cash Expenses Management Fees NonCashExpensesManagementFees		usd
CY2023Q1	KOAN	Gain Loss On Settlement Of Notes Payable GainLossOnSettlementOfNotesPayable		usd
CY2022Q1	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1		usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount		usd
CY2023Q1	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross		usd
CY2022Q4	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross		usd
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	000-21202
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	Resonate Blends, Inc.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	58-1588291
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	26565 Agoura Road
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 200
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Calabasas
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	91302
CY2023Q1	dei	City Area Code CityAreaCode	571
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	888-0009
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	76664877	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1042	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	64419	usd
CY2023Q1	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	120000	usd
CY2022Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	150000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	115072	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	160492	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	236114	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	374911	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	21106	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	24110	usd
CY2023Q1	us-gaap	Equity Method Investments EquityMethodInvestments	100	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	100	usd
CY2023Q1	us-gaap	Assets Assets	257320	usd
CY2022Q4	us-gaap	Assets Assets	399121	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	236894	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	319618	usd
CY2023Q1	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1507712	usd
CY2022Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	988800	usd
CY2023Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	212438	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	72487	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	2026144	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1545851	usd
CY2023Q1	us-gaap	Liabilities Liabilities	2026144	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1545851	usd
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	7544	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	7544	usd
CY2023Q1	KOAN	Common Stock Issuable CommonStockIssuable	6000	usd
CY2023Q1	KOAN	Stocks Subscription Receivable StocksSubscriptionReceivable	-261059	usd
CY2022Q4	KOAN	Stocks Subscription Receivable StocksSubscriptionReceivable	-261059	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	24179867	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	24427009	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-25701376	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-25320424	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-1768824	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-1146730	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	257320	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	399121	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10107	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	27652	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	8572	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	12857	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	1535	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	14795	usd
CY2023Q1	us-gaap	Advertising Expense AdvertisingExpense	13284	usd
CY2022Q1	us-gaap	Advertising Expense AdvertisingExpense	165471	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	67172	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	27516	usd
CY2023Q1	KOAN	Legal And Professional Fees LegalAndProfessionalFees	12965	usd
CY2022Q1	KOAN	Legal And Professional Fees LegalAndProfessionalFees	25675	usd
CY2023Q1	us-gaap	Officers Compensation OfficersCompensation	5000	usd
CY2022Q1	us-gaap	Officers Compensation OfficersCompensation	235000	usd
CY2022Q1	KOAN	Non Cash Expenses Management Fees NonCashExpensesManagementFees	201957	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	98421	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	655619	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-96886	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-640824	usd
CY2023Q1	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	46403	usd
CY2022Q1	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	22457	usd
CY2023Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-139951	usd
CY2022Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	1166839	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	97712	usd
CY2022Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	31795	usd
CY2022Q1	KOAN	Gain Loss On Settlement Of Notes Payable GainLossOnSettlementOfNotesPayable	18277	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-284066	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1130864	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-380952	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	490040	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	75437604	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	47796859	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-4101931	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	131525	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	202047	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	490040	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-3278319	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-1146730	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-1146730	usd
CY2023Q1	KOAN	Reclassification Of Convertible Debt ReclassificationOfConvertibleDebt	-247142	usd
CY2023Q1	KOAN	Exercise Of Warrant ExerciseOfWarrant	6000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-380952	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-1768824	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-1768824	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-380952	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	490040	usd
CY2023Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-139951	usd
CY2022Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	1166839	usd
CY2023Q1	KOAN	Non Cash Interest Expense NonCashInterestExpense	97712	usd
CY2022Q1	KOAN	Non Cash Interest Expense NonCashInterestExpense	22457	usd
CY2022Q1	KOAN	Gain On Settlement Of Notes Payable GainOnSettlementOfNotesPayable	-18277	usd
CY2022Q1	KOAN	Share Professional Fees Compensation ShareProfessionalFeesCompensation	201957	usd
CY2023Q1	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	3004	usd
CY2022Q1	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	3004	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-45420	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	23531	usd
CY2022Q1	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	12951	usd
CY2023Q1	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-30000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	210134	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	20754	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	145269	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-483386	usd
CY2022Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	650000	usd
CY2022Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	5000	usd
CY2023Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	6000	usd
CY2023Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	95846	usd
CY2023Q1	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	118800	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-208646	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	655000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-63377	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	171614	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	64419	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	12913	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1042	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	184527	usd
CY2013Q4	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	The Company also voted to approve a 1 for 5 reverse split of its outstanding common stock.
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-25701376	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_842_eus-gaap--UseOfEstimates_z84OB9LP0Bw3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_zTq0PI5vffUh">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2023Q1	us-gaap	Derivative Instruments In Hedges Liabilities At Fair Value DerivativeInstrumentsInHedgesLiabilitiesAtFairValue	212438	usd
CY2022Q4	us-gaap	Derivative Instruments In Hedges Liabilities At Fair Value DerivativeInstrumentsInHedgesLiabilitiesAtFairValue	72487	usd
CY2023Q1	KOAN	Property And Equipment Excess Capitalized Cost PropertyAndEquipmentExcessCapitalizedCost	1000	usd
CY2023Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	1000	usd
CY2023Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	1535000	usd
CY2022Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	988800	usd
CY2023Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	27288	usd
CY2023Q1	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	1507712	usd
CY2022Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	988800	usd
CY2023Q1	us-gaap	Notes Payable NotesPayable	200000	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	200000	usd
CY2023Q1	us-gaap	Debt Instrument Convertible Threshold Percentage Of Stock Price Trigger DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger	0.73	pure
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0.030
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	3.38	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	2.20	pure
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	4.50	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	1.45	pure
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P1Y
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2019Q4	us-gaap	Lessee Operating Lease Description LesseeOperatingLeaseDescription	the Company signed a lease agreement that expires on thirty days’ notice. Rent expense was approximately $6,280 and $1,165 for the three months ended March 31, 2023 and 2022, respectively
CY2023Q1	us-gaap	Payments For Rent PaymentsForRent	6280	usd
CY2022Q1	us-gaap	Payments For Rent PaymentsForRent	1165	usd
CY2023Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	6000	usd
CY2023Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	249255	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	249255	shares

Files In Submission

Name	View Source	Status
0001493152-23-018479-index-headers.html	Edgar Link	pending
0001493152-23-018479-index.html	Edgar Link	pending
0001493152-23-018479.txt	Edgar Link	pending
0001493152-23-018479-xbrl.zip	Edgar Link	pending
ex3-1.htm	Edgar Link	pending
ex3-1_001.jpg	Edgar Link	pending
ex3-1_002.jpg	Edgar Link	pending
ex3-1_003.jpg	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
form10-q_001.jpg	Edgar Link	pending
koan-20230331.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
koan-20230331_cal.xml	Edgar Link	unprocessable
koan-20230331_def.xml	Edgar Link	unprocessable
koan-20230331_lab.xml	Edgar Link	unprocessable
koan-20230331_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$KOAN
Resonate Blends Inc Stock $koan

2023 Q2 Form 10-Q Financial Statement

#000149315223018479 Filed on May 22, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KOAN Resonate Blends Inc Stock $koan

2023 Q2 Form 10-Q Financial Statement

#000149315223018479 Filed on May 22, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KOAN
Resonate Blends Inc Stock $koan